147 related articles for article (PubMed ID: 22460679)
1. Discrepancy between fluorescence in situ hybridization and multiplex ligation-dependent probe amplification in orbital recurrence of uveal melanoma 26 years after enucleation.
Russo A; Rene C; Coupland SE; Sagili S; Damato B
Ophthalmic Plast Reconstr Surg; 2012; 28(6):e140-2. PubMed ID: 22460679
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal 3 and 8 status within hepatic metastasis of uveal melanoma.
Singh AD; Tubbs R; Biscotti C; Schoenfield L; Trizzoi P
Arch Pathol Lab Med; 2009 Aug; 133(8):1223-7. PubMed ID: 19653714
[TBL] [Abstract][Full Text] [Related]
3. Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death.
Damato B; Dopierala J; Klaasen A; van Dijk M; Sibbring J; Coupland SE
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3048-55. PubMed ID: 19182252
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetics and prognosis for uveal melanoma in Korean patients.
Lee CS; Lee J; Choi JJ; Yang WI; Yoon JS; Lee SY; Lee SC
Acta Ophthalmol; 2011 Jun; 89(4):e310-4. PubMed ID: 21310015
[TBL] [Abstract][Full Text] [Related]
5. Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma.
Vaarwater J; van den Bosch T; Mensink HW; van Kempen C; Verdijk RM; Naus NC; Paridaens D; Brüggenwirth HT; Kiliç E; de Klein A
Melanoma Res; 2012 Feb; 22(1):30-7. PubMed ID: 22157614
[TBL] [Abstract][Full Text] [Related]
6. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
Parrella P; Caballero OL; Sidransky D; Merbs SL
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
[TBL] [Abstract][Full Text] [Related]
7. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetics of uveal melanoma: a 7-year clinical experience.
Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
[TBL] [Abstract][Full Text] [Related]
9. Two Distinct Uveal Melanomas in the Same Eye.
Nissen EJ; Kalirai H; Damato B; Heimann H; Coupland SE
JAMA Ophthalmol; 2015 Sep; 133(9):1094-6. PubMed ID: 26110363
[No Abstract] [Full Text] [Related]
10. The ocular consequences and applicability of minimally invasive 25-gauge transvitreal retinochoroidal biopsy.
Bagger M; Tebering JF; Kiilgaard JF
Ophthalmology; 2013 Dec; 120(12):2565-2572. PubMed ID: 24053996
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.
Larsen AC; Holst L; Kaczkowski B; Andersen MT; Manfé V; Siersma VD; Kolko M; Kiilgaard JF; Winther O; Prause JU; Gniadecki R; Heegaard S
Acta Ophthalmol; 2014 Sep; 92(6):541-9. PubMed ID: 24373459
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical and molecular pathology of ocular uveal melanocytoma: evidence for somatic GNAQ mutations.
Mudhar HS; Doherty R; Salawu A; Sisley K; Rennie IG
Br J Ophthalmol; 2013 Jul; 97(7):924-8. PubMed ID: 23685997
[TBL] [Abstract][Full Text] [Related]
13. Ciliary body melanoma with partial deletion of chromosome 3 detected with multiplex ligation-dependent probe amplification.
Damato EM; Damato B; Sibbring JS; Coupland SE
Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1637-40. PubMed ID: 18563430
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
15. Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma.
Smit KN; van Poppelen NM; Vaarwater J; Verdijk R; van Marion R; Kalirai H; Coupland SE; Thornton S; Farquhar N; Dubbink HJ; Paridaens D; de Klein A; Kiliç E
Mod Pathol; 2018 May; 31(5):763-771. PubMed ID: 29327717
[TBL] [Abstract][Full Text] [Related]
16. Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma.
Bronkhorst IH; Maat W; Jordanova ES; Kroes WG; Schalij-Delfos NE; Luyten GP; Jager MJ
Arch Pathol Lab Med; 2011 Aug; 135(8):1042-7. PubMed ID: 21809997
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Factors Five Years After Enucleation for Uveal Melanoma.
Dogrusöz M; Brouwer NJ; de Geus SJR; Ly LV; Böhringer S; van Duinen SG; Kroes WGM; van der Velden PA; Haasnoot GW; Marinkovic M; Luyten GPM; Kivelä TT; Jager MJ
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):31. PubMed ID: 32186672
[TBL] [Abstract][Full Text] [Related]
18. Risk factors associated with secondary enucleation after fractionated stereotactic radiotherapy in uveal melanoma.
van den Bosch T; Vaarwater J; Verdijk R; Muller K; Kiliç E; Paridaens D; de Klein A; Naus N
Acta Ophthalmol; 2015 Sep; 93(6):555-60. PubMed ID: 25879399
[TBL] [Abstract][Full Text] [Related]
19. Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma.
Lake SL; Kalirai H; Dopierala J; Damato BE; Coupland SE
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2647-52. PubMed ID: 22427594
[TBL] [Abstract][Full Text] [Related]
20. Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8.
van Gils W; Kilic E; Brüggenwirth HT; Vaarwater J; Verbiest MM; Beverloo B; van Til-Berg ME; Paridaens D; Luyten GP; de Klein A
Melanoma Res; 2008 Feb; 18(1):10-5. PubMed ID: 18227702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
